Cycurion, Inc. (CYCU): Entry into a Material Definitive Agreement
Cycurion, Inc. (CYCU) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 3 ex10-1.htm EX-10.1 Exhibit 10.1 Cycurion, Inc. 1640 Boro Place, Suite 420C McLean, Virginia July 30, 2026 To the Holder of Common Stock Purchase Warrants Issued in December 2025 Re: Inducement Offer to Exercise Existing Shares of Common Stock Purchase Warrants Dear Hold
How this was made
The 30-second read
Why it matters
This is a capital-structure event. The inducement reduces the effective exercise price for existing warrants and offers additional warrant coverage (150% of the shares issuable under existing warrants), which can increase future dilution but also brings forward cash from warrant exercises.
Market read
Traders may reprice CYCU’s dilution and financing outlook based on expected warrant exercise participation and the timing of stockholder approval for new warrant exercisability.
What to watch
New warrants are exercisable only after Nasdaq stockholder approval, and beneficial ownership limits may constrain immediate share issuance, delaying dilution impact.
Background
The 8-K (Item 1.01) includes an inducement offer to holders of common stock purchase warrants issued in December 2025, with new unregistered warrants issued upon exercise of existing warrants.
Ticker impact
Cycurion entered a material definitive agreement offering warrant holders inducement to exercise existing warrants and receive new warrants on different terms.
Near-term volatility possible around warrant exercise participation and resulting share issuance, but direction is uncertain without the current warrant holder base and CYCU’s cash needs.
The filing specifies offer size (up to 5,012,159 new warrants), exercise price changes ($3.62 to $1.35 for existing exercise; new warrants at $1.65), and a $4.51M aggregate exercise consideration, which are concrete drivers of dilution and capital inflow expectations.
Market effects
Microcap biotech/tech issuers using warrant inducements may signal ongoing capital-raising needs, which can affect sentiment toward similar balance-sheet-light names.
No clear regional spillover beyond US-listed small caps.
Limited global relevance; primarily affects CYCU’s capital structure and trading dynamics.
Counterpoint
If participation is high, the cash inflow from exercising existing warrants could reduce immediate financing risk, making the dilution overhang less bearish than it appears.
Key entities
- issuerCycurion, Inc.
Subject of the 8-K, offering inducement to exercise existing common stock purchase warrants and issue new warrants.
- securityCommon stock purchase warrants (Existing Warrants, issued Dec 5, 2025)
Existing warrants with an exercise price of $3.62 per share, targeted for cash exercise during the exercise period.
- securityNew common stock purchase warrants (New Warrants)
Unregistered warrants offered as inducement, exercisable after stockholder approval, with a $1.65 exercise price and 5-year term.
